Journal
NATURE REVIEWS GENETICS
Volume 23, Issue 2, Pages 69-70Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41576-021-00430-z
Keywords
-
Categories
Funding
- University of Bologna
- IRCCS Istituto delle Scienze Neurologiche
- National Institutes of Health [NIH U54 NS078059]
- Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF) from the J. Willard and Alice S. Marriott Foundation
- Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimento Saludable [CIBERFES16/10/00282]
- Severo Ochoa Program for Centers of Excellence [SEV-2015-0505]
- Wellcome Trust in the Medical Research Council Mitochondrial Biology Unit [212219/Z/18/Z, MC_UU_00015/9]
- NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]
Ask authors/readers for more resources
Individual cells in the same iPSC-derived clones exhibit large heterogeneity, with emerging evidence suggesting that variants in mitochondrial DNA play a pivotal role. Single-cell analyses have shown significant differences in the transcriptome between individual cells in the same iPSC-derived clones, which are partly attributable to genetic and epigenetic modifications of the nuclear genome.
Individual cells in the same induced pluripotent stem cell (iPSC)-derived clones can exhibit large heterogeneity. In this Comment, Carelli et al. discuss emerging evidence implicating variants in mitochondrial DNA, and highlight the need for routine screening of iPSCs. Single-cell analyses in recent years have shown major differences in the transcriptome between individual cells in the same induced pluripotent stem cell-derived clones. Although these differences are in part attributable to genetic and epigenetic modifications of the nuclear genome, emerging evidence suggests that variants in mitochondrial DNA also play a pivotal role.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available